None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The present study prospectively collected clinical data from patients who underwent TKA in our institute from May 2017 to December 2019. The inclusion criterion was primary osteoarthritis (OA) patients who underwent unilateral TKA using a cemented, posterior-stabilized prosthesis.
Exclusion criteria
Exclusion criteria: Patients with secondary OA were not eligible for inclusion in this study; those with a second knee in staged bilateral TKA, cruciate-retaining type of prosthesis, or a tibia stem fixation for primary TKA were also excluded. Exclusion criteria also included presence of major comorbidities such as severe ischemic heart disease, severe pulmonary disease, severe renal insufficiency, hepatic failure, coagulopathy, and a history of arterial or venous thromboembolic disease (cerebrovascular accident, deep vein thrombosis, or pulmonary thromboembolism).
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| estimated blood loss;transfusion rate;clinical complications | — |
Primary
| Measure | Time frame |
|---|---|
| hemoglobin drop;total drainage amount | — |
Countries
Korea, Republic of
Contacts
Kyung Hee University Hospital at Gangdong